Guest guest Posted May 25, 2004 Report Share Posted May 25, 2004 I have to agree with aegis comments on keep the LDN lobbying targeted to results for MS. That is the way scientists and medical researchers think .They will immediately turn off, if a whole list of diseases which could improve I,f treated with LDN, is listed.This is the way medicine is TAUGHT and the way they are trained to think, over years. I spent my whole life around medical researchers and science people. They still do heaps of good work ,even if their taught vertical thinking. At the most you could mention the results of the INITIAL trial with Crohn disease because the results were so outstanding .But remember ,that is only ONE trial. I also think people should start to give Dr Lawrence's advice ,on the bodies ACCOMDATION to lDN, more time and consider that it is a very real possibility that LDN will become less effective over time and we should start to incorporate his 'TIMEOFF"ldn ,seriously into our programmes. (Dr bihari has only had one patient on it for a long time,over 10 years, and she was a very new rrms and young and there are some of us who"ve had 20 years between big relapses) We do need a trial but one done properly ...and repeatable. ( and then the price of ldn will soar ,if the history of pharmaceuticals holds.........) My two cents worth. Louise OZ Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.